research Real-Life Dosing of Biologics in Plaque Psoriasis—A German Survey
Real-life dosing of biologics for plaque psoriasis often deviates from recommended guidelines, especially for high-need patients.
Search
forLearn
0 / 0 results — no results
Research
5 / 19 results 
research Cataract Surgery Guidelines in Europe: A Literature Review and Document Search in 15 Countries
Cataract surgery guidelines vary across Europe, and generic finasteride sales for hair loss have grown due to pill splitting.
research Economic Analysis of Cataract Surgery in Europe: An Analysis of Hospital Databases Available in 11 Countries
Cataract surgery in Europe varies in frequency and cost between countries.
research The Impact of Potential Pill Splitting on Generic and Branded Finasteride Uptake
Pill splitting increased generic finasteride sales but didn't affect branded finasteride sales.
research Cost Comparison of Patients with Chronic Hand Eczema Covered by Statutory vs. Occupational Health Insurances in Germany
Treating chronic hand eczema costs about the same in statutory and occupational health insurances in Germany, but work-related cases may lead to higher indirect costs due to longer work absences.
Community Join
4 / 4 resultscommunity GT20029 - Promising phase II results
GT20029 showed significant hair growth and safety in phase II trials, with no adverse sexual events. Users are hopeful but concerned about future costs and systemic effects.
community GT20029 China Phase II Trial For AGA Reached Primary Endpoint
The GT20029 tincture, a topical androgen receptor degrader, showed significant hair growth and good safety in a China Phase II trial for male androgenetic alopecia (AGA), with the 1% dose twice weekly identified as optimal. The company plans to initiate Phase III trials in China and Phase II in the U.S., and the treatment also shows promise for acne.
community Target Area Hair Count (TAHC) increase comparasion of all future treatments in clinical trial phases
Finasteride, Minoxidil, Bioneer CosmeRNA, Technoderma, Kintor, Hope, Breezula, and Follicum treatments showed increases in hair count, with Technoderma showing the highest increase at 24.3 hairs/cm². Amplifica has not yet published results.
community Breaking hair loss news! GT20029 is a resounding success!
GT20029, a new hair loss treatment, shows promising results but only a slight improvement over placebo. People are cautiously optimistic, discussing its potential and combining it with existing treatments like Minoxidil and Finasteride.